Brain fog after lymphoma: study probes lasting cognitive effects of chemotherapy
NCT ID NCT07652476
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at thinking skills, memory, and quality of life in people who are 3 to 5 years past successful treatment for Hodgkin lymphoma or certain types of B-cell lymphoma. Participants take a series of tests and questionnaires once during a regular follow-up visit. The goal is to understand how common cognitive problems are after treatment and what factors might be linked to them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study finds clear patterns of cognitive decline, it could lead to better monitoring and support for lymphoma survivors.
- What could go wrong
- This is an observational study with only 100 participants, so results may not apply to all survivors. It does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLASSIC HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica di Ematologia, AOU Ospedali Riuniti
Ancona, Italy
-
Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano
Aviano, Italy
-
Ematologia - AOU Policlinico Giaccone
Palermo, Italy
-
Ematologia - Ospedale Maggiore Policlinico - Fondazione IRCCS Ca Granda
Milan, Italy
-
SC Ematologia - ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
-
U.O.C Ematologia - IRCCS Istituto Tumori Giovanni Paolo II
Bari, Italy
-
U.O.C. Ematologia Ospedale Civile di Legnano - ASST Ovest Milanese
Legnano, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo keep aggressive lymphoma at bay?
- Can a simple blood test spot lymphoma earlier?
- Can a 'Universal' cancer target outsmart resistant blood cancers?
- Can a single shot build a cancer army inside the body?
- Can a smart immune cell with a kill switch beat tough lymphomas?
- Ultra-Fast CAR-T cells aim to beat back tough lymphomas